600 patients66,869 observations120 daysLIVE
← Patients

Patient P-01500

Synthetic patientNBL-101 · Day 97 · 25–34 · F · baseline S01Steering view · 3DOpen companion preview
Therapy response
Favorable
Tolerance
Favorable
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Improving
Discontinuation risk
2%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 started — Baseline state S01
  2. Day 17 Trajectory diverged from prediction — Observed response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 17.

Primary contributors, last 14 days
  • GI instability-25
  • Inflammatory activity-16
  • Nutritional resilience+11
  • Toxicity-2

What helped?

No interventions yet.

    LIFE OS recommendation
    No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    GI burden
    Companion
    0/100
    improving · -9.7 vs previous 14 d
    Toxicity
    Blood
    13.7/100
    worsening · +0.5 vs previous 14 d
    Sleep quality
    Wearable
    57.5/100
    improving · +5.7 vs previous 14 d
    Energy level
    Daily log
    6.9/10
    improving · +0.7 vs previous 14 d
    Stress level
    Daily log
    3/10
    improving · -0.6 vs previous 14 d
    Steps
    Wearable
    10,501
    stable · +328 vs previous 14 d
    Adherence
    Companion
    92.7 %
    stable · -2.7 vs previous 14 d
    This trajectory is doing well — what to keep, what to watch
    Steering view →

    Heading towards restoration · 109 from the failing basin, 23 from restoration.

    Good elements to keep
    • Butyrate producers intact
      hidden · steering +7.5
    • Daily walks resumed
      perturbation · steering +3.3
    Main detractors to watch
    • Bacteroides fragilis elevated
      hidden · steering -7.4
    • Antibiotic course
      perturbation · steering -4.7
    • Poor-sleep week
      perturbation · steering -3
    • Dietary drift
      perturbation · steering -2.6
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Alcohol
      -2.2no signal · 36%
    • Spicy / capsaicin
      -1no signal · 17%
    • Histamine load
      +0.6no signal · 15%
    • Dietary fat load
      +0.5no signal · 15%
    • Simple carbohydrates
      +0.5no signal · 15%
    • Insoluble fibre
      -0.5no signal · 15%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Inflammatory signalling ↓20
      • MicrobiomeBacteroides fragilis expansion
    DNA
    Fictional pharmacogenomic panel
    • CYP2D6 Normal metabolizer
      Expected exposure
    Microbiome
    Shannon diversity 4 · butyrate capacity 61/100
    • Akkermansia muciniphilaNormal
    • Faecalibacterium prausnitziiNormal
    • Bacteroides fragilisHigh
    • Bifidobacterium longumLow
    • EnterobacteriaceaeNormal
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    47 ms
    Sleep
    6.5 h
    Steps
    9,344
    Resting HR
    57 bpm
    Daily log: GI score 0, nutritional resilience 76, adherence 93.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Keep fibre steady; no new sources this week
    • Avoid known triggers for now: fried or oily food, dairy, alcohol
    What to do
    • Log the daily check-in; one line is enough
    • Keep the current walking rhythm
    • Keep the sleep window steady
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the scheduled dose as agreed with your care team
    • No additional supplements this week
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    Sort by similaritySort by interventionSort by outcomeSort by stateSort by response
    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0176634%S05AD-05no change90
    P-0180426%S19AD-05improved61
    P-0154124%S09AD-05no change43
    P-0167742%S05BR-03no change86
    P-0149536%S07BR-03improved85
    P-0132934%S08BR-03improved79
    P-0146825%S06BR-03no change41
    P-0165436%S08CR-01improved85
    P-0143025%S05CR-01improved54
    P-0147941%S15DT-01improved84
    P-0185534%S04DT-01improved73
    P-0172431%S10DT-01improved63